keyword
https://read.qxmd.com/read/38645331/new-salicylanilide-derivatives-and-their-peptide-conjugates-as-anticancer-compounds-synthesis-characterization-and-in-vitro-effect-on-glioblastoma
#1
JOURNAL ARTICLE
Lilla Horváth, Beáta Biri-Kovács, Zsuzsa Baranyai, Bence Stipsicz, Előd Méhes, Bálint Jezsó, Martin Krátký, Jarmila Vinšová, Szilvia Bősze
Pharmacologically active salicylanilides (2-hydroxy- N -phenylbenzamides) have been a promising area of interest in medicinal chemistry-related research for quite some time. This group of compounds has shown a wide spectrum of biological activities, including but not limited to anticancer effects. In this study, substituted salicylanilides were chosen to evaluate the in vitro activity on U87 human glioblastoma (GBM) cells. The parent salicylanilide, salicylanilide 5-chloropyrazinoates, a 4-aminosalicylic acid derivative, and the new salicylanilide 4-formylbenzoates were chemically and in vitro characterized...
April 16, 2024: ACS Omega
https://read.qxmd.com/read/38645276/restoring-cellular-copper-homeostasis-in-alzheimer-disease-a-novel-peptide-shuttle-is-internalized-by-an-atp-dependent-endocytosis-pathway-involving-rab5-and-rab14-endosomes
#2
JOURNAL ARTICLE
Michael Okafor, Olivia Champomier, Laurent Raibaut, Sebahat Ozkan, Naima El Kholti, Stéphane Ory, Sylvette Chasserot-Golaz, Stéphane Gasman, Christelle Hureau, Peter Faller, Nicolas Vitale
CPPs, or Cell-Penetrating Peptides, offer invaluable utility in disease treatment due to their ability to transport various therapeutic molecules across cellular membranes. Their unique characteristics, such as biocompatibility and low immunogenicity, make them ideal candidates for delivering drugs, genes, or imaging agents directly into cells. This targeted delivery enhances treatment efficacy while minimizing systemic side effects. CPPs exhibit versatility, crossing biological barriers and reaching intracellular targets that conventional drugs struggle to access...
2024: Frontiers in Molecular Biosciences
https://read.qxmd.com/read/38642503/conjugation-of-sulpiride-with-a-cell-penetrating-peptide-to-augment-the-antidepressant-efficacy-and-reduce-serum-prolactin-levels
#3
JOURNAL ARTICLE
Yuan Liang, Yu Yang, Ruiyan Huang, Jiangyue Ning, Xingyan Bao, Zelong Yan, Haotian Chen, Li Ding, Chang Shu
Depression ranks as the fourth most prevalent global disease, with suicide incidents occurring at a younger age. Sulpiride (SUL), an atypical antidepressant drug acting as a dopamine D2 receptor antagonist and possessing anti-inflammatory properties, exhibits limited ability to penetrate the blood brain barrier (BBB). This weak penetration hampers its inhibitory effect on prolactin release in the pituitary gland, consequently leading to hyperprolactinemia. In order to enhance the central nervous system efficacy of sulpiride and reduce serum prolactin levels, we covalently linked sulpiride to VPALR derived from the nuclear DNA repair protein ku70...
April 19, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38637801/prediction-of-blood-brain-barrier-penetrating-peptides-based-on-data-augmentation-with-augur
#4
JOURNAL ARTICLE
Zhi-Feng Gu, Yu-Duo Hao, Tian-Yu Wang, Pei-Ling Cai, Yang Zhang, Ke-Jun Deng, Hao Lin, Hao Lv
BACKGROUND: The blood-brain barrier serves as a critical interface between the bloodstream and brain tissue, mainly composed of pericytes, neurons, endothelial cells, and tightly connected basal membranes. It plays a pivotal role in safeguarding brain from harmful substances, thus protecting the integrity of the nervous system and preserving overall brain homeostasis. However, this remarkable selective transmission also poses a formidable challenge in the realm of central nervous system diseases treatment, hindering the delivery of large-molecule drugs into the brain...
April 19, 2024: BMC Biology
https://read.qxmd.com/read/38637546/disruption-of-the-pro-oncogenic-c-raf-pde8a-complex-represents-a-differentiated-approach-to-treating-kras-c-raf-dependent-pdac
#5
JOURNAL ARTICLE
Sean F Cooke, Thomas A Wright, Yuan Yan Sin, Jiayue Ling, Elka Kyurkchieva, Nattaporn Phanthaphol, Thomas Mcskimming, Katharine Herbert, Selma Rebus, Andrew V Biankin, David K Chang, George S Baillie, Connor M Blair
Pancreatic ductal adenocarcinoma (PDAC) is considered the third leading cause of cancer mortality in the western world, offering advanced stage patients with few viable treatment options. Consequently, there remains an urgent unmet need to develop novel therapeutic strategies that can effectively inhibit pro-oncogenic molecular targets underpinning PDACs pathogenesis and progression. One such target is c-RAF, a downstream effector of RAS that is considered essential for the oncogenic growth and survival of mutant RAS-driven cancers (including KRASMT PDAC)...
April 18, 2024: Scientific Reports
https://read.qxmd.com/read/38636118/targeted-drug-loaded-peptides-induce-tumor-cell-apoptosis-and-immunomodulation-to-increase-antitumor-efficacy
#6
JOURNAL ARTICLE
Hongjie Li, Peirong Zhang, Xiaomeng Yuan, Shan Peng, Xingyue Yang, Yuxia Li, Zhen Shen, Jingkun Bai
Immunotherapy is an emerging approach for the treatment of solid tumors. Although chemotherapy is generally considered immunosuppressive, specific chemotherapeutic agents can induce tumor immunity. In this study, we developed a targeted, acid-sensitive peptide nanoparticle (DT/Pep1) to deliver doxorubicin (DOX) and triptolide (TPL) to breast cancer cells via the enhanced permeability and retention (EPR) effect and the breast cancer-targeting effect of peptide D8. Compared with administration of the free drugs, treatment with the DT/Pep1 system increased the accumulation of DOX and TPL at the tumor site and achieved deeper penetration into the tumor tissue...
April 16, 2024: Biomater Adv
https://read.qxmd.com/read/38633589/incorporation-of-three-extracyclic-arginine-residues-into-a-melanocortin-macrocyclic-agonist-c-pro-his-dphe-arg-trp-dap-lys-arg-arg-arg-ac-dpro-decreases-food-intake-when-administered-intrathecally-or-subcutaneously-compared-to-a-macrocyclic-ligand-lacking
#7
JOURNAL ARTICLE
Mark D Ericson, Katie T Freeman, Courtney M Larson, Jacob L Bouchard, Kristen John, Mary M Lunzer, Zoe M Koerperich, Carrie Haskell-Luevano
Of the three Food and Drug Administration-approved melanocortin peptide drugs, two possess a cyclic scaffold, demonstrating that cyclized melanocortin peptides have therapeutic relevance. An extracyclic Arg residue, critical for pharmacological activity in the approved melanocortin cyclic drug setmelanotide, has also been demonstrated to increase the signal when fluorescently labeled cell-penetrating cyclic peptides are incubated with HeLa cells, with the maximal signal observed with three extracyclic Arg amino acids...
April 12, 2024: ACS Pharmacology & Translational Science
https://read.qxmd.com/read/38626918/unique-advantages-of-dendrimers-structured-mesoporous-silica-nanoparticles-over-traditional-hollow-ones-in-delivering-bcl2-functional-converting-peptide-for-multidrug-resistant-cancer-treatment
#8
JOURNAL ARTICLE
Yuehuang Wu, Fangmei Ma, Lixue Yu, Ruimiao Lin, Sijin Lin, Zhihan Guo, Min Zhou, Mingyu Li, Yi Zhang, Jingjing Xie
Innovative silica nanomaterials have made the significant advancements in curative therapy against cancers with multidrug resistance (MDR). The study on different-nanostructured mesoporous silica nanoparticles (MSNs) with discrepant pore sizes affecting biomacromolecules in resisting cancer MDR hasn't been reported yet. In this study, a systematic comparison of 6 nm-pore sized hollow-structured MSNs (HMSNs) and 10 nm-pore sized dendrimers-structured MSNs (LMSNs) for delivering Bcl-2-functional converting peptide (N9) or doxorubicin (DOX) to overcome cancer MDR was comprehensively carried out both in in vitro and in vivo resistant tumor models...
April 16, 2024: Advanced Healthcare Materials
https://read.qxmd.com/read/38623284/cell-penetrating-peptides-noncovalently-modified-red-phosphorescent-nanoparticles-for-high-efficiency-imaging
#9
JOURNAL ARTICLE
Zihan Luo, Zhuofan Zhou, Yiwen Pan, Zece Zhu, Huanxiang Yuan, Yutao Li, Shumin Feng, Yi Hong, Li Xu
The application of long-lived phosphorescence probes in time-resolved luminescence imaging is limited by their low quantum yield in aqueous solutions. However, sensitization of thermally activated delayed fluorescence (TADF) materials can compensate for this limitation while addressing the issue of insufficient proportion of their own long lifetime. In this study, we utilized the characteristics of phosphorescence and TADF materials simultaneously by doping the receptor iridium complex PMD-Ir into the donor TADF polymer PCzDP-20 through donor-receptor doping method, and successfully prepared highly efficient red phosphorescent nanoparticles...
April 10, 2024: RSC Advances
https://read.qxmd.com/read/38622637/antimicrobial-peptide-thanatin-fused-endolysin-pa90-tha-pa90-for-the-control-of-acinetobacter-baumannii-infection-in-mouse-model
#10
JOURNAL ARTICLE
Jeonghyun Lim, Heejoon Myung, Daejin Lim, Miryoung Song
BACKGROUND: This study addresses the urgent need for infection control agents driven by the rise of drug-resistant pathogens such as Acinetobacter baumannii. Our primary aim was to develop and assess a novel endolysin, Tha-PA90, designed to combat these challenges. METHODS: Tha-PA90 incorporates an antimicrobial peptide (AMP) called thanatin at its N-terminus, enhancing bacterial outer membrane permeability and reducing host immune responses. PA90 was selected as the endolysin component...
April 15, 2024: Journal of Biomedical Science
https://read.qxmd.com/read/38621565/functional-modification-of-recombinant-brain-derived-neurotrophic-factor-and-its-protective-effect-against-neurotoxicity
#11
JOURNAL ARTICLE
Chang Liu, Qi Yan, Xuying Ding, Meijun Zhao, Chen Chen, Qian Zheng, Huiying Yang, Yining Xie
Brain-derived neurotrophic factor (BDNF) is a neurotrophic protein that promotes neuronal survival, increases neurotransmitter synthesis, and has potential therapeutic effects in neurodegenerative and psychiatric diseases, but its drug development has been limited by the fact that recombinant proteins of BDNF are unstable and do not penetrate the blood-brain barrier (BBB). In this study, we fused a TAT membrane-penetrating peptide with BDNF to express a recombinant protein (TBDNF), which was then PEG-modified to P-TBDNF...
April 13, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38615194/optimizing-properties-of-translocation-enhancing-transmembrane-proteins
#12
JOURNAL ARTICLE
Ladislav Bartoš, Martina Drabinová, Robert Vácha
Cell membranes act as semi-permeable barriers, often restricting the entry of large or hydrophilic molecules. Nonetheless, certain amphiphilic molecules, like antimicrobial and cell-penetrating peptides, can cross these barriers. In this study, we demonstrate that specific properties of transmembrane proteins/peptides can enhance membrane permeation of amphiphilic peptides. Using coarse-grained molecular dynamics with free energy calculations, we identify key translocation-enhancing attributes of transmembrane proteins/peptides: a continuous hydrophilic patch, charged residues preferably in the membrane center, and aromatic hydrophobic residues...
April 12, 2024: Biophysical Journal
https://read.qxmd.com/read/38614014/synthesis-and-biological-evaluation-of-egfr-binding-peptides-for-near-infrared-photoimmunotherapy
#13
JOURNAL ARTICLE
Takuya Otani, Motofumi Suzuki, Hideo Takakura, Hirofumi Hanaoka
Near-infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment that involves photoimmunotherapy drug injection and NIR light exposure. In NIR-PIT, antibodies are commonly used as target-directed molecules carrying IRDye700DX (IR700). However, antibodies have disadvantages, such as high cost, complex development strategies, and poor tumor penetration. In contrast, peptides have lower production costs, can be easy to chemically synthesize and modify, and can also be used for tumor-targeting like antibodies...
April 10, 2024: Bioorganic & Medicinal Chemistry
https://read.qxmd.com/read/38613996/the-use-of-a-selective-nontoxic-dual-acting-peptide-for-breast-cancer-patients-with-brain-metastasis
#14
JOURNAL ARTICLE
Marco Cavaco, Clara Pérez-Peinado, Javier Valle, Ruben D M Silva, Lurdes Gano, João D G Correia, David Andreu, Miguel A R B Castanho, Vera Neves
Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by the absence of commonly targeted receptors. Unspecific chemotherapy is currently the main therapeutic option, with poor results. Another major challenge is the frequent appearance of brain metastasis (BM) associated with a significant decrease in patient overall survival. The treatment of BM is even more challenging due to the presence of the blood-brain barrier (BBB). Here, we present a dual-acting peptide (PepH3-vCPP2319) designed to tackle TNBC/BM, in which a TNBC-specific anticancer peptide (ACP) motif (vCPP2319) is joined to a BBB peptide shuttle (BBBpS) motif (PepH3)...
April 12, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38605742/recombinant-production-of-tp4-lyc1-a-new-chimeric-peptide-with-targeted-cytotoxicity-to-hela-cells
#15
JOURNAL ARTICLE
Hanieh Mohammad Pour, Ali Jahanian-Najafabadi, Fatemeh Shafiee
BACKGROUND: Tilapia Piscidin 4 (TP4) showed potential anti-tumor effects against various cancer cells. Lycosine-1 (LYC1), is another Antimicrobial Peptides (AMP) from spider venom with targeted penetration to cancer cells without any adverse effects on normal cells. The aim of this study was to produce a soluble recombinant fusion peptide in order to diminish the cytotoxicity of TP4 against normal cells. METHODS: In order to express of TP4-LYC-1, TP4, and LYC1 in fusion to the inteins1/2 of pTWIN-1 vector, induction condition was optimized to earn soluble peptides...
2024: Avicenna Journal of Medical Biotechnology
https://read.qxmd.com/read/38602391/adamantylglycine-as-a-high-affinity-peptide-label-for-membrane-transport-monitoring-and-regulation
#16
JOURNAL ARTICLE
Malavika Pramod, Mohammad A Alnajjar, Sandra N Schöpper, Thomas Schwarzlose, Werner M Nau, Andreas Hennig
The non-canonical amino acid adamantylglycine (Ada) is introduced into peptides to allow high-affinity binding to cucurbit[7]uril (CB7). Introduction of Ada into a cell-penetrating peptide (CPP) sequence had minimal influence on the membrane transport, yet enabled up- and down-regulation of the membrane transport activity.
April 11, 2024: Chemical Communications: Chem Comm
https://read.qxmd.com/read/38598682/correction-to-structural-elucidation-of-the-cell-penetrating-penetratin-peptide-in-model-membranes-at-the-atomic-level-probing-hydrophobic-interactions-in-the-blood-brain-barrier
#17
Swapna Bera, Rajiv K Kar, Susanta Mondal, Kalipada Pahan, Anirban Bhunia
No abstract text is available yet for this article.
April 10, 2024: Biochemistry
https://read.qxmd.com/read/38596030/biomimetic-nanocarriers-loaded-with-temozolomide-by-cloaking-brain-targeting-peptides-for-targeting-drug-delivery-system-to-promote-anticancer-effects-in-glioblastoma-cells
#18
JOURNAL ARTICLE
Huaming Chen, Yunhong Wang, Hai Wang, Kun Zhang, Yunfei Liu, Qiangfeng Li, Chengli Li, Zhonghui Wen, Ziyu Chen
Glioma is the leading cancer of the central nervous system (CNS). The efficacy of glioma treatment is significantly hindered by the presence of the blood-brain barrier (BBB) and blood-brain tumour barrier (BBTB), which prevent most drugs from entering the brain and tumours. Hence, we established a novel drug delivery nanosystem of brain tumour-targeting that could self-assemble the method using an amphiphilic Zein protein isolated from corn. Zein's amphiphilicity prompted it to self-assembled into NPs, efficiently containing TMZ...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38595046/effects-of-pna-sequence-and-target-site-selection-on-function-of-a-4-5s-non-coding-rna
#19
JOURNAL ARTICLE
Snehlata Saini, Khushboo Goel, Sudipta Ghosh, Anirban Das, Ishu Saraogi
Peptide nucleic acid (PNA) based antisense strategy is a promising therapeutic approach to specifically inhibit target gene expression. However, unlike protein coding genes, identification of an ideal PNA binding site for non-coding RNA is not straightforward. Here, we compare the inhibitory activities of PNA molecules that bind a non-coding 4.5S RNA called SRP RNA, a key component of the bacterial signal recognition particle (SRP). A 9-mer PNA (PNA9) complementary to the tetraloop region of the RNA was more potent in inhibiting its interaction with the SRP protein, compared to an 8-mer PNA (PNA8) targeting a stem-loop...
April 9, 2024: Chembiochem: a European Journal of Chemical Biology
https://read.qxmd.com/read/38589287/a-quantitative-method-to-distinguish-cytosolic-from-endosome-trapped-cell-penetrating-peptides
#20
JOURNAL ARTICLE
Françoise Illien, Zoltán Bánóczi, Sandrine Sagan
Cell-penetrating peptides are known to penetrate cells through endocytosis and translocation. The two pathways are hardly distinguished in current cell assays. We developed a reliable, simple and robust method to distinguish and quantify independently the two routes. The assay requires (DABCYL) 4-(dimethylaminoazo)benzene-4-carboxylic acid- and (CF) carboxyfluorescein-labeled peptides. When the labeled peptide is intact, the fluorescence signal is weak thanks to the dark quenching property of DABCYL. A 10-fold higher fluorescence signal is measured when the labeled peptide is degraded...
April 8, 2024: Chembiochem: a European Journal of Chemical Biology
keyword
keyword
18776
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.